What are the decisions you should be making now to successfully launch into 2020?

Pharma’s future has never looked more promising – or more ominous. Major scientific, technological and socioeconomic changes will revive the industry’s fortunes in another decade, but capitalising on these trends entail that you first make some very crucial decisions.

We believe the pharmaceutical industry is at a critical juncture. The tools to develop remarkable, new medicines are materialising, demand for the industry’s products is increasing and the barriers to free trade are falling. But pharma also faces major economic and operational challenges if it’s to capitalise on these opportunities and create more value for healthcare payers, providers and patients.

There are a number of things companies can do to both increase the chances of reaching 2020 and to ready themselves for more favourable conditions thereafter.
_______________________________________________________

We have the pleasure of inviting you to our seminar “From vision to decision”, where we will focus on the areas requiring the most important decision-making as we move towards 2020.

Jo Pisani, Partner, Pharmaceutical and Life Sciences, Strategy, PwC UK will present highlights from our global report, and you will also have the opportunity to meet and discuss your issues with our specialists within the pharma industry.

The report “From vision to decision” and other reports from the Pharma 2020 series are available on our website www.pwc.se/pharma

Welcome!